Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue...
Drug safety advice
- Ergot-derived dopamine agonists: risk of fibrotic reactions in chronic endocrine uses
- Use of antibiotics in premature labour: latest information
Yellow Card scheme update
- When to report an adverse drug reaction
Hot topic
- Pseudoephedrine and ephedrine nasal decongestants: risk of illicit use
Stop Press
- Theophylline: narrow therapeutic index and potential for misuse
Other information from the MHRA
- Central Alerting System: access to urgent safety guidance
- Patient Information Leaflet of the month: Livial (tibolone)
- Unlicensed medicines: latest imports
- Consultation: dispensing opticians and access to prescription medicines
Drug Safety Update: Volume 2, Issue 3 October 2008 
